PURIFICATION OF HEMATOPOIETIC STEM CELLS BY A CD117 MONOCLONAL ANTIBODY,MTK1, IN ORDER TO TRANSFECT HUMAN GENES-A PRELIMINARY STUDY
PURIFICATION OF HEMATOPOIETIC STEM CELLS BY A CD117 MONOCLONAL ANTIBODY,MTK1, IN ORDER TO TRANSFECT HUMAN GENES-A PRELIMINARY STUDY
批准号:
06454295
负责人:
TSUCHIYA Shigeru
金额:
$4.29万
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (B)
财政年份:
1994
资助国家:
日本
项目状态:
已结题
起止时间:
1994 至 1995
中文摘要
通过对Balb/c小鼠免疫急性巨核母细胞白血病细胞系(M-MOK)细胞,我们产生了2种单克隆抗体,MTK1和MTK2,对CD117 (c-kit)具有特异性。我们发现用MTK1和免疫磁珠以及CD34抗体和磁珠治疗骨髓单核细胞能够纯化造血干细胞(CFU-GM和BUFU-E)。为了了解CD117的分期和谱系特异性表达,我们检测了白血病细胞和白血病细胞系。CD117表达约70%的髓系白血病细胞。在白血病细胞的体外适应过程中,我们注意到CD117在巨核/红巨核细胞系上的显性表达,但其机制仍在研究中。为了以不同的方式表征骨髓造血细胞,我们检测了IL-2受体γ - c链在CD34阳性细胞上的表达。我们发现大约40%的CD34阳性细胞表达γ - c链。然后我们检测了CD34 (+) γ c链(+)和CD34 (+) γ c链(-)细胞中CFU-GM和BFU-E的数量。与CD34 (+) γ c链(+)细胞相比,CD34 (+) γ c链(+)细胞含有更多的BFU-E。两组CFU-GM无显著差异。我们尝试用电穿孔法在GM-CSF依赖的M-MOK细胞中引入bcr/abl cDNA,作为基因转染造血细胞的初步实验。经G418筛选的M-MOK细胞经RT-PCR证实存在Bcr/abl cDNA。而依赖GM-CSF的M-MOK细胞在bcr/abl cDNA的影响下不转化为不依赖细胞因子的细胞。为了将基因引入造血干细胞,似乎有许多关于载体和靶细胞的问题需要尽快解决。
英文摘要
By immunizing an acute megakaryoblastic leukemia cell line (M-MOK) cells to Balb/c mice we have produced 2 monoclonal antibodies, MTK1 and MTK2, with the specificity to CD117 (c-kit). We found that treatment of bone marrow mononuclear cells with the MTK1 and immunomagnetic beads, as well as a CD34 antibody and the beads, was able to purify hematopoietic stem cells (CFU-GM and BUFU-E). In ordor to know stage and lineage specific expression of CD117 we examined leukemic cells and leukemia cell lines. CD117 expressed approximately 70% of myeloid leukemia cells. During in vitro adapation of leukemic cells dominant expression of CD117 on the cell lines with megakaryo/erythromegakaryocytic lineage was noticed, but the mechanism was still under investigation.To characterize bone marrow hematopoietic cells in a different way we examined the expression of the IL-2 receptor gamma c chains on CD34 positive cells. We found that approximately 40% of CD34 positive cells expressed gamma c chains. Then we examined the number of CFU-GM and BFU-E in CD34 (+) gamma c chain (+) and CD34 (+) gamma c chain (-) cells. CD34 (+) gamma c chain (-) cells contained more BFU-E as compared with those of CD34 (+) gamma c chain (+) cells. No differences were observed for CFU-GM in these 2 fractions.We tried to introduce bcr/abl cDNA in GM-CSF dependent M-MOK cells by an electroporation method as a preliminary experiment of transfection of genes to hematopoietic cells. Presence of Bcr/abl cDNA in M-MOK cells after selection by G418 was confirmed by a RT-PCR method. However, GM-CSF dependent M-MOK cells were not converted to cytokine independent one under the influence of bcr/abl cDNA.In order to introduce genes to hematopoietic stem cells there seemed to be many things concerning vectors and target cells which should be solved soon.
期刊论文(48)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Morita S et al: "Cell surface c-kit receptors in human leukemia cell lines and padlatric leukeima : Selective oreservation of c-kit expression on megakaryoblastic cell lines" Leukemia. 10. 102-105 (1996)
Morita S 等人:“人类白血病细胞系和白斑白血病中的细胞表面 c-kit 受体:巨核细胞系上 c-kit 表达的选择性保留”白血病。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Fujie H ET AL: "bcr/abl mRNAs in leukemic blasts of an unusual patient with acute lymphoblastic leukemia after 5-year remission by chronic myelogenous leukemia in blast crisis." Leukemia. 8. 1592-1595 (1994)
Fujie H 等人:“一名不寻常的急性淋巴细胞白血病患者在急变期慢性粒细胞白血病缓解 5 年后,其白血病急变期中的 bcr/abl mRNA 水平。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Itano M et al: "Establishment and characterization of a novel human immature megakaryoblastic leukemia cell line, M-MOK, dependent on ffibroblasts for its viablity" Exp Hematol. 23. 1301-1309 (1995)
Itano M 等人:“新型人类未成熟巨核细胞白血病细胞系 M-MOK 的建立和表征,其活力依赖于成纤维细胞”Exp Hematol。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Ishii N: "Impairment of ligand binding and growth signaling of mutant IL-2 receptor γ chains in patients with・・・" J.Immunol.153. 1310-1317 (1994)
Ishii N:“突变 IL-2 受体 γ 链患者的配体结合和生长信号传导受损……”J.Immunol.153(1994)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Ohashi Y: "A new point mutation involving a highly conserved leucine in the βtk SH2 domain in a family with・・・" J.Med Genetics. (印刷中). (1995)
Ohashi Y:“一种新的点突变,涉及一个家族中 βtk SH2 结构域中的高度保守的亮氨酸”,J.Med Genetics(1995 年出版)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 23 条
Homologous recombination-mediated gene correction in iPS cells o Ornithine transcarbamylase deficiency
-
批准号:23659511
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.33万
-
财政年份:2011
-
负责人:TSUCHIYA Shigeru
-
依托单位:
Leukemogenesis due to insertional mutagenesis-a NOG mouse model-
-
批准号:19390280
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.56万
-
财政年份:2007
-
负责人:TSUCHIYA Shigeru
-
依托单位:
Induction of human cytotoxic T cells by peptide-pulsed universal antigen presenting cells
-
批准号:16390294
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.22万
-
财政年份:2004
-
负责人:TSUCHIYA Shigeru
-
依托单位:
GENE THERAPY FOR X-LINKED SEVERE COMBINED IMMUNODEFICIENCY DISEASE
-
批准号:14370240
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.02万
-
财政年份:2002
-
负责人:TSUCHIYA Shigeru
-
依托单位:
MECHANISM OF INFECTION OF EPSTEIN-BARR VIRUS TO T AND NK CELLS
-
批准号:12470165
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.41万
-
财政年份:2000
-
负责人:TSUCHIYA Shigeru
-
依托单位:
TARGET CELL SPECIFIC GENE TRANSFER BY ANTIFECTION AND REGULATION OF PROLIFERATION OF CANCER CELLS
-
批准号:10470173
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$7.49万
-
财政年份:1998
-
负责人:TSUCHIYA Shigeru
-
依托单位:
Function of the gene of Wiskott-Aldrich syndrome
-
批准号:08457219
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$0.9万
-
财政年份:1996
-
负责人:TSUCHIYA Shigeru
-
依托单位:
ESTABLISHMENT AND CHARACTERIZATION OF AN IMMATURE MYELOID CELL LINE, M-MOK, GROWN IN THE PRESENCE OF FIBROBLAST-FEEDER CELLS
-
批准号:03454260
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$3.71万
-
财政年份:1991
-
负责人:TSUCHIYA Shigeru
-
依托单位:
Etiology of congenital agammaglobulinemia: Growth defect of precursor B lymphoblastoid cell lines and immunoglobulin gene rearrangements.
-
批准号:62480224
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$3.97万
-
财政年份:1987
-
负责人:TSUCHIYA Shigeru
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于氧化应激介导的SCF/c-kit系统探讨靶向菌群调控ASD情绪及社交行为障碍的机制研究
-
批准号:JCZRLH202600725
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
C-KIT激酶区突变调控SET在儿童急性髓系白血病耐药中的作用及机制研究
-
批准号:JCZRLH202500940
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
基于预训练和自监督构建多模态基础模型以辅助预测胃肠道间质瘤c-KIT/PDGFRA基因突变分型及预后模型的研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:郑静
-
依托单位:
八味解郁汤通过调控SCF/c-kit/Akt信号通路对功能性消化不良大鼠氧化应激损伤及肠胃动力的影响
-
批准号:2025JJ80922
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:邹君君
-
依托单位:
c-kit信号通过PATZ1-MFN1促进骨骼干细胞线粒体融合加速老年患者骨折愈合
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:--
-
批准年份:2024
-
负责人:单华建
-
依托单位:
基于空间分辨代谢组学研究莪术醇调控RSPO- LGR4/5-ZNRF3/RNF43轴及C-kit紊乱重塑LSECs空间异质和肝分区带性紊乱抗肝纤维化的作用机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:黎桂玉
-
依托单位:
LncRNA MEG3/Hedgehog途径抑制c-Kit阳性前体间充质细胞向ICC分化导致儿童肾盂输尿管连接部梗阻的机制研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:--
-
批准年份:2024
-
负责人:李佳
-
依托单位:
miR-221-3p 靶向 c-kit 介导 SCF/c-kit 调控 ICC 自噬影响肠动力机制及枳术丸干预研究
-
批准号:2024JJ7358
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:夏旭婷
-
依托单位:
c-kit调控MAPK-MFN1信号增强骨骼干细胞线粒体融合促进老年患者骨折愈合
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:白超文
-
依托单位:
索拉非尼靶向c-Kit抑制Skp2介导的DNA损伤修复增强阿糖胞苷对t(8;21)急性髓系白血病细胞杀伤及机理研究
-
批准号:82370152
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:史鹏程
-
依托单位: